← back to search

Adrian L. Harris

Cancer Research Center · GB
🔎 Find collaborators in Cancer Research · Molecular Biology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer, Hypoxia, and Metabolism, Angiogenesis and VEGF in Cancer, RNA modifications and cancer, and Cancer, Lipids, and Metabolism.
h-index
187
citations
156,760
works
2,085
NIH funding
primary concept
email

Recent publications

SET1B Drives Sustained HIF activity and Disease Progression in Clear Cell Renal Cell Carcinoma.
2026cited by 0position: contributordoi
The breast tumor microenvironment exploits eosinophil plasticity to suppress their anti-tumor activity
2026cited by 0position: contributordoi
SET1B drives sustained HIF activity and disease progression in clear cell renal cell carcinoma
2025cited by 0position: contributordoi
A systems-based approach to uterine fibroids identifies differential splicing associated with abnormal uterine bleeding.
2025cited by 0position: contributordoi
Amyloid-β disrupts APP-regulated protein aggregation and dissociation from recycling endosomal membranes.
2025cited by 0position: contributordoi
Supplementary Figures from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner
2025cited by 0position: contributordoi
Supplementary Data from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner
2025cited by 0position: contributordoi
SET1B Drives Sustained HIF Activity and Disease Progression in Clear-Cell Renal Cell Carcinoma
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 0position: middledoi
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles 2024cited by 3,400position: middledoi
Autophagy Blockage Up-Regulates HLA-Class-I Molecule Expression in Lung Cancer and Enhances Anti-PD-L1 Immunotherapy Efficacy.
2024cited by 3position: contributordoi
Low cytoplasmic NUB1 protein exerts hypoxic cell death with poorer prognosis in oestrogen receptor negative breast cancer patients.
2024cited by 1position: contributordoi
A systems-based approach to uterine fibroids identifies differential splicing associated with abnormal uterine bleeding
2024cited by 1position: contributordoi
APP and β-amyloid modulate protein aggregation and dissociation from recycling endosomal and exosomal membranes
2024cited by 0position: contributordoi
Data from GTP cyclohydrolase drives breast cancer development and promotes EMT in an enzyme-independent manner
2024cited by 0position: contributordoi
Supplementary Data from GTP cyclohydrolase drives breast cancer development and promotes EMT in an enzyme-independent manner
2024cited by 0position: contributordoi
Supplementary Figures from GTP cyclohydrolase drives breast cancer development and promotes EMT in an enzyme-independent manner
2024cited by 0position: contributordoi
Supplementary Figures from GTP cyclohydrolase drives breast cancer development and promotes EMT in an enzyme-independent manner
2024cited by 0position: contributordoi
Supplementary Data from GTP cyclohydrolase drives breast cancer development and promotes EMT in an enzyme-independent manner
2024cited by 0position: contributordoi
Is it still worth pursuing the repurposing of metformin as a cancer therapeutic?
2023cited by 95position: contributordoi
Accessory ESCRT‐III proteins are conserved and selective regulators of Rab11a‐exosome formation
Journal of Extracellular Vesicles 2023cited by 75position: middledoi
Targeting mitochondrial oxidative phosphorylation: lessons, advantages, and opportunities.
2023cited by 33position: contributordoi
A Rab6 to Rab11 transition is required for dense-core granule and exosome biogenesis in Drosophila secondary cells.
2023cited by 11position: contributordoi
GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner.
2023cited by 11position: contributordoi
Metabolic Reprogramming in Colon Cancer Cells Persistently Infected with Newcastle Disease Virus.
2023cited by 4position: contributordoi
Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) Using Generative Adversarial Network Augmented Deep Learning Model.
2023cited by 3position: contributordoi
Metabolic Symbiosis between Oxygenated and Hypoxic Tumour Cells: An Agent-based Modelling Study
2023cited by 1position: contributordoi
Hypoxia inducible factors inhibit respiratory syncytial virus infection by modulation of nucleolin expression
2023cited by 1position: contributordoi
A Rab6 to Rab11 transition is required for dense-core granule and exosome biogenesis in<i>Drosophila</i>secondary cells
2023cited by 0position: contributordoi
Stress-induced Rab11a-exosomes induce AREG-mediated cetuximab resistance in colorectal cancer
2023cited by 0position: contributordoi
Predicting Breast Cancer Events in Ductal Carcinoma In Situ (DCIS) using Generative Adversarial Network Augmented Deep Learning Model
2023cited by 0position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 114 papers (2019–2026)Helen Sheldon · University of Oxford27 papers (2021–2023)Francesca M. Buffa · Science Oxford27 papers (2019–2023)Cameron Snell · Mater Health Services26 papers (2021–2023)Uzi Gileadi · MRC Human Immunology Unit25 papers (2021–2023)Ildefonso Silva · Cancer Research UK Oxford Centre25 papers (2021–2023)Roman Fischer · Oxford BioMedica (United Kingdom)20 papers (2019–2025)Esther Bridges · Medical Research Council15 papers (2022–2025)Shijie Cai · John Radcliffe Hospital14 papers (2023–2025)David Kerr · Seattle University14 papers (2023–2025)Zhu Liang · Molecular Discovery (United Kingdom)14 papers (2023–2025)Philip Hublitz · Evotec (Germany)14 papers (2023–2025)Wei Zhang · Nuffield Health14 papers (2023–2025)Yao Jiang · Center for Drug Evaluation and Research14 papers (2023–2025)Balázs Gyorffy · Royal Canadian Navy14 papers (2023–2025)Zijing Wang · Shanghai Mental Health Center14 papers (2023–2025)Jiabien Liang · Fujian Medical University14 papers (2023–2025)Aik Seng Ng · Institute of Molecular and Cell Biology14 papers (2023–2025)Qi Luo · First Affiliated Hospital of Xiamen University14 papers (2023–2025)Xin Zeng · Affiliated Hospital of Southwest Medical University14 papers (2023–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cancer Research · Molecular Biology →